201. Response to autoimmune enteropathy to cyclosporin A therapy.
- Author
-
Sanderson IR, Phillips AD, Spencer J, and Walker-Smith JA
- Subjects
- Autoimmune Diseases metabolism, Autoimmune Diseases pathology, Child, Female, Glucose metabolism, Growth drug effects, Humans, Intestinal Absorption drug effects, Intestinal Diseases metabolism, Intestinal Diseases pathology, Intestine, Small ultrastructure, Male, Autoimmune Diseases drug therapy, Cyclosporine therapeutic use, Intestinal Diseases drug therapy
- Abstract
Small bowel enteropathies that are associated with an autoimmune process are often resistant to treatment. Two children with autoimmune enteropathy were treated with cyclosporin A for eight months. Both improved, as assessed by growth, small intestinal mucosal morphology, and carbohydrate absorption. Cyclosporin A is useful in the treatment of autoimmune enteropathy. This report also suggests that T cell activation (which is suppressed by cyclosporin A) is important in the pathogenesis of this condition.
- Published
- 1991
- Full Text
- View/download PDF